Optimization and validation of an HPLC-UV method for analysis of clozapine and its major metabolites in human plasma Klozapin ve major metabolitlerinin İnsan plazmasinda analizi İçin bir YPSK-UV metodunun optimizasyon ve validasyonu


Dural E., Mergen G., Söylemezoğlu T.

Turkish Journal of Pharmaceutical Sciences, vol.12, no.2, pp.177-186, 2015 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.5505/tjps.2015.68077
  • Journal Name: Turkish Journal of Pharmaceutical Sciences
  • Journal Indexes: Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.177-186
  • Keywords: Clozapine, Clozapine-N-oxide, HPLC-UV, Norclozapine, Optimization
  • Ankara University Affiliated: Yes

Abstract

© 2015, Turkish Pharmacists Association. All rights reserved.A simple, simultaneous and reliable HPLC method was developed for analysis of clozapine that is a widely prescribed drug especially for treatment of schizophrenia, but may have fatal toxicities in some cases. Its two metabolites are norclozapine and clozapine N-oxide in human plasma. Chromatographic conditions and detection parameters were adjusted in consequence of optimization study. An isocratic high-performance liquid chromatography method with ultraviolet detection at 220nm was utilized. Analytes are concentrated from plasma by liquid–liquid extraction with ethyl acetate, n-hexane and isopropylalcohol (80:15:5,v/v/v) which allows to obtain good extraction yields (>80%) for all analytes. Separation was performed on a C18 reversed-phase column using a mixture of acetonitrile and 62.4mM phosphate buffer (containing 0.3%triethylamine, pH4.5) at the ratio of 40:60(v/v). Method showed linearity with excellent correlation coefficients (r2>0.999) for each analyte. The relative standard deviations and relative standard errors calculated to present precision and accuracy between and withinday assay were less than 4% for low concentrations. The method was specific and sensitive with detection limits of 23.6μg/L, 19.3μg/L and 23.6μg/L for clozapine, norclozapine and clozapine N-oxide respectively. The procedure described is relatively simple, precise, and applicable for routine therapeutic drug monitoring especially in psychiatry clinics or in toxicology reference laboratories.